Clinical Trials Logo

Clinical Trial Summary

The objective of this proposal is to determine the effect of resistance exercise training on locomotor muscle function, exercise capacity, exertional symptoms, and quality of life in HF patients with preserved ejection fraction (HFpEF).


Clinical Trial Description

In this randomized controlled pilot study of resistance exercise training in patients with HFpEF, the investigators will recruit 24 HFpEF patients who will be randomized to resistance exercise training (RT - n=12) or no resistance exercise training (standard care control group [CTL] - n=12). The investigators will have baseline and follow-up measures of clinical characteristics, leg muscle strength, quality of life, lean muscle mass (body composition via DXA including segmental lean mass), maximal cardiopulmonary exercise test (peak VO2, peak work, ventilatory efficiency), constant-load submaximal cardiopulmonary exercise test with speckle tracking echocardiography (exertional dyspnea and fatigue at matched workloads, cardiac output, diastolic function, left ventricular strain, ventilation, gas exchange, and locomotor muscle neural feedback). Participants will be asked to make 4 separate study visits. Those randomized to undergo Resistance Training will be expected to make those visits as well. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02435667
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date June 2015
Completion date January 2021

See also
  Status Clinical Trial Phase
Recruiting NCT06338943 - Middle-aged Women With Adverse Pregnancy Outcomes and Heart Failure With Preserved Ejection Fraction
Recruiting NCT06057623 - Neuromuscular Fatigue and Exercise Capacity in Patients With Type 2 Diabetes Mellitus and HFpEF
Not yet recruiting NCT06467266 - Mechanistic Insights From Temporary Pacing in HFpEF N/A
Recruiting NCT06215586 - Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF) Phase 2
Recruiting NCT05888233 - Allopurinol Improves Heart Function in African Americans With Resistant Hypertension Phase 2